My current trades with MRK and XLE are doing well – tempted to close XLE out, take the profit and move into something else – but I don’t see any obvious contenders:
| Name | Ticker | Price | Fair Value | Margin of Safety | Yield % | MOS % |
| Amgen Inc | AMGN | $142.59 | $194.00 | $51.41 | 2.09 | 26.50% |
| ITC Holdings Corp | ITC | $32.45 | $42.00 | $9.55 | 2.11 | 22.74% |
| Merck & Co Inc | MRK | $50.88 | $65.00 | $14.12 | 3.59 | 21.72% |
| Wal-Mart Stores Inc | WMT | $65.46 | $79.00 | $13.54 | 3 | 17.14% |
| Spectra Energy Partners LP | SEP | $41.50 | $50.00 | $8.50 | 5.79 | 17.00% |
| Exxon Mobil Corporation | XOM | $76.46 | $92.00 | $15.54 | 3.74 | 16.89% |
| Philip Morris International Inc | PM | $80.98 | $92.00 | $11.02 | 5.03 | 11.98% |
| Magellan Midstream Partners, L.P. | MMP | $68.00 | $76.00 | $8.00 | 4.26 | 10.53% |
| 3M Co | MMM | $145.14 | $160.00 | $14.86 | 2.74 | 9.29% |
| Johnson & Johnson | JNJ | $94.26 | $99.00 | $4.74 | 3.09 | 4.79% |
Based on the following screen:
- Stocks to Own Screen:
- Morningstar analysis available.
- Low fair value uncertainty.
- Wide moat.
- Morningstar rating 4 or more stars.
- Financial Health Grade >= B.
- Current P/E <= 20.
Leave a Reply